Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, provided an update on its regulatory and initial deployment activities for its telehealth platform in Venezuela. The Company is advancing early-stage deployment, testing, and refinement of its platform, which is accessible through its digital interface at https://latamedai.org. The platform is designed to support remote patient engagement, care coordination, and integration of AI-driven healthcare analytics tools.
Current efforts focus on enhancing platform functionality, improving data integration, and optimizing the user experience. In parallel, the Company is working with the Ministerio del Poder Popular para la Salud, including the Servicio Autónomo de Contraloría Sanitaria (SACS), to obtain the required Permiso Sanitario de Funcionamiento para Plataforma Digital. Management anticipates that the permitting process may be completed in the near term, but no assurance can be provided regarding timing or outcome.
Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated: "Our focus is on building a scalable telehealth platform that can operate effectively within real-world healthcare environments. We are currently advancing platform testing, refinement, and regulatory alignment as we continue to build the foundation for broader deployment across Latin America. We expect a full launch in short order and upon receiving all regulatory approvals."
The Company believes this phase of deployment, testing, and regulatory alignment represents an important step toward broader operational rollout across its target markets. For more information, visit https://catalystcrewai.com or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
